Reports
Sale
Global Clinical Laboratory Tests Market Size, Share, Growth: By Test Type: Complete Blood Count, Basic Metabolic Panel Testing, HGB/ HCT testing, Comprehensive Metabolic Panel Testing, BUN Creatinine Testing, Others; By Category; By Patient Type; By Service Provider; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Clinical Laboratory Tests Market Size
The global clinical laboratory tests market was valued at USD 230.99 billion in 2023 driven by the growth of technological advancements and growing rate of chronic diseases across the globe. The market is estimated to grow at a CAGR of 7.2% in the forecast period of 2024-2032 and reach a market value of USD 431.86 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Clinical Laboratory Tests Market Outlook
- Clinical laboratories are centres of massive relevance within the healthcare setting. It greatly enhances the diagnosis of patients and the planning of their treatment regimens.
- The expansion of healthcare industries and laboratory automation is attributed to several factors. These include the advancement of healthcare reforms. They are also elements of adopting new technologies and diagnosis system advancement.
- Several trends are shaping the current and future landscape of clinical laboratory tests. It includes a shift to molecular diagnostics and point-of-care testing. It also includes the use of artificial intelligence and big data analytics in healthcare ecosystem.
Clinical Laboratory Tests Market Overview
Clinical laboratory tests are important in identifying a disease and assessing the effectiveness of treatment. These range from simple chemical tests to advanced molecular methods for testing and identifying. It plays an important role in producing and delivering essential diagnostic products and services for diseases. The market growth is driven due to increased use of technology and rising prevalence of chronic diseases are more common. It helps doctors make informed health decisions, diagnose conditions, and recommend treatments while making sure patients get the right treatments. Both general and specific labs play a big role in patient management.
Clinical Laboratory Tests Market Growth Drivers
Rising Popularity of Preventive Healthcare Influencing Market Growth
Rising chronic diseases and increasing healthcare costs are driving the preventive healthcare market growth. It emphasizes preventing disease instead of treating it. Age, gender, and general body check-ups are becoming more common primary methods for diagnosing and treating diseases. For example, women aged 38 to 42 should get mammograms to screen for breast cancer, leading to increased frequency of clinical lab tests. This trend is significantly affecting the market, pointing to the need for improved diagnostic solutions.
Growing Interest of Businesses in Building Automated Clinical Laboratories
One of the major factors contributing to market growth includes the increasing interest of key players in integrating automation to enhance laboratory functionality. Automation offers several benefits such as replacing pre-existing manual processes, increasing capacity, and improving results quality, thus driving market development.
For example, in April 2023, Flow Robotics launched the ScanID device featuring 1D and 2D scanners designed to optimise sample identification and minimise errors during the pre-analytical phase. Hence, such product launches are expected to play an important role in supporting the infrastructure and lead to operation of automated laboratories.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Clinical Laboratory Tests Market Trends
| Key Trends | Impact |
| Rising Adoption of Molecular Diagnostics | The widespread adoption of molecular diagnosis systems and allied tests due to genomic programming and personalized therapies has significantly improved the diagnostic accuracy of various biomarkers and disease indicators. Thus, it is propelling market growth. |
| Growing of Point-of-Care Testing (POCT) | Increasing use of point-of-care testing (POCT) is amongst the major market trends, where tests are conducted close to or at the patient’s side for quick results. POCT offers faster test results and patient care. It is convenient for implementation across various clinical areas, and it generally enhances patient outcomes influencing its growing adoption. |
| Increasing Focus on Liquid Biopsies | Blood-based liquid biopsy sampling methods, such as circulating tumor DNA (ctDNA) and other biomarkers are increasingly integrated into clinical practice for cancer detection, treatment monitoring, and recurrence tracking. These liquid biopsies are mostly noninvasive and provide real-time results, enhancing cancer diagnoses and helping with personalized treatments for cancer patients. |
| Integration of Big Data Analytics and Artificial Intelligence | Integrating AI and big data incorporation in medical analysis is rapidly changing clinical laboratory testing. Such technologies provide healthcare applied sciences with various tools for perception patterns, analytical projections, and decision-making aids, thus making diagnosis efficient, enhancing organizational productivity, and significantly contributing to patients' well-being. |
Recent Innovations in the Clinical Laboratory Tests Market
In March 2024, Neurocode USA launched ALZpath Dx, which is a blood test for screening, diagnosing, and tracking Alzheimer’s disease. This innovative test measures the levels of pTau217 in the bloodstream, offering valuable insights into the disease’s progression and severity. AlzheiDAits Dx represents significant advancements in Alzheimer's diagnostics by providing a less invasive and efficient method for early detection, ultimately improving patient care and treatment.
In March 2023, Quest Diagnostics announced the launch of an Expanded Test Panel post-COVID-19, offering consumers additional diagnostic tests. This panel includes a complete blood count (CBC), basic metabolic panel (BMP), and hepatic function panel tests. These tests are important not only for assessing ongoing health issues related to the COVID-19 virus but also for helping with informed discussions between patients and healthcare providers regarding their health concerns.
In March 2023, Fluxergy finalized the acquisition of InnaMed Blood Testing Tech, marking a significant step towards integrating metabolic panel creation using electrochemical biosensors with HomeLab™ instrument and analysis software. This strategic move lets Fluxergy enhance its capabilities in identifying and tracking a range of biomarkers critical for diagnostics, such as glucose level, electrolytes, hormones, liver enzymes, and cardiac enzymes. This acquisition positions Fluxergy to offer more effective diagnostic options through advanced technology and expanded analytical capabilities.
Clinical Laboratory Tests Market Segmentation
Market Breakup by Test Type
- Complete Blood Count
- Basic Metabolic Panel Testing
- HGB/ HCT testing
- Comprehensive Metabolic Panel Testing
- BUN Creatinine Testing
- HbA1c Testing
- Electrolytes Testing
- Liver Panel Testing
- Hepatitis
- Liver Cirrhosis
- Bone Disease
- Bile Duct Obstruction
- Liver Cancer
- Autoimmune Disorders
- Others
- Lipid Panel Testing
- Renal Panel Testing
- Cardiovascular Panel Tests
- Others
Market Breakup by Category
- Clinical Chemistry
- Genetics
- Cytology
- Hematology
- Microbiology
- Immunology
Market Breakup by Patient Type
- Adult
- Geriatrics
Market Breakup by Service Provider
- Hospital-based Laboratories
- Stand-alone Laboratories
- Clinic-based Laboratories
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Clinical Laboratory Tests Market Share
Hospital-Based Laboratories is Anticipated to Have the Largest Market Share Based on Service Provider
The market segmentation by service provider is divided into hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. Among these hospital-based laboratories are poised to lead the market because of its well-developed infrastructure and patient access. Its direct interface with patients makes tests and diagnoses efficient. This prevalence shapes the modern market environment, indicating preference towards integrated care and increasing demand for innovative diagnostic equipment. On the other hand, stand-alone and clinic-based laboratories provide specialized services and accessible services thus propelling the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Clinical Laboratory Tests Market Analysis by Region
The clinical laboratory tests market is categorized into different regions, namely, North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. Out of these, North America dominates the market due to its superior healthcare facilities, high healthcare spending, and advanced research and development in medicine. The United States with its highly developed healthcare system leads the market.
In Asia Pacific region, rising incidence of chronic diseases, improved healthcare frameworks, and growing awareness of preventive care are key factors contributing to the market growth. Meanwhile, Latin America, the Middle East, and Africa are also experiencing growth, driven by development such as increased access to quality healthcare services and increased governmental initiatives aimed at improving healthcare facilities.
Leading Players in the Clinical Laboratory Tests Market
The key features of the market report include strategic initiatives constituting recent partnerships and collaborations as well as funding and investments by the leading players. The major companies in the market are as follows:
ARUP Laboratories
It is a US based company founded in 1984. They are known for their advanced diagnostic immunoassays, genetic testing, and specialized testing services. The company got the approval from FDA for a diagnostic immunoassay, AAV5 DetectCDx™.
Opko Health, Inc.
Established in 1991 and based in Florida, United States, the company has many laboratories like BioReference Laboratories and GenPath Oncology laboratories that provide clinical laboratory testing services covering molecular diagnostics. They also focused on personalized medicine and diagnostic innovations.
NeoGenomics Laboratories, Inc.
Founded in 2002 and headquartered in the United States, the company specializes in oncology testing services including immunohistochemistry (IHC), in situ hybridization (ISH), and molecular testing (PCR), morphologic evaluation.
Eurofins Scientific
This is a Luxembourg-based company established in 1987. The company offers an extensive portfolio of genetic testing services including noninvasive prenatal testing (NIPT), molecular genetics, pharmacogenomics, and environmental testing.
Other companies include Bioscientia Institut für Medizinische Diagnostik GmbH, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Spectra Laboratories, Inc., SYNLAB International, Quest Diagnostics Incorporated.
Kindly note that this only represents a partial list of companies and the complete list has been in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Category |
|
| Breakup by Patient Type |
|
| Breakup by Service Provider |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Questions Answered in the Clinical Laboratory Tests Market
- What was the global clinical laboratory tests market value in 2023?
- What is the global clinical laboratory tests market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What are the major factors aiding the global clinical laboratory tests market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience rapid growth during the forecast period?
- What are the major global clinical laboratory tests market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the clinical laboratory tests market?
- What are the current unmet needs and challenges?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
- What are the primary test types conducted in the clinical laboratory tests market?
- Which categories are most significant in the clinical laboratory tests market?
- What types of service providers dominate the clinical laboratory tests market?
- What factors are driving the growth in the Asia-Pacific region?
- How are other regions such as Latin America, the Middle East, and Africa performing in the market?
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Laboratory Tests Market Overview
3.1 Global Clinical Laboratory Tests Market Historical Value (2017-2023)
3.2 Global Clinical Laboratory Tests Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Clinical Laboratory Tests Market Landscape*
5.1 Global Clinical Laboratory Tests: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Clinical Laboratory Tests: Product Landscape
5.2.1 Analysis by Test Type
5.2.2 Analysis by Category
6 Global Clinical Laboratory Tests Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Clinical Laboratory Tests Market Segmentation (2017-2032)
7.1 Global Clinical Laboratory Tests Market (2017-2032) by Test Type
7.1.1 Market Overview
7.1.2 Complete Blood Count
7.1.3 Basic Metabolic Panel Testing
7.1.4 HGB/ HCT testing
7.1.5 Comprehensive Metabolic Panel Testing
7.1.6 BUN Creatinine Testing
7.1.7 HbA1c Testing
7.1.8 Electrolytes Testing
7.1.9 Liver Panel Testing
7.1.9.1 Hepatitis
7.1.9.2 Liver Cirrhosis
7.1.9.3 Bone Disease
7.1.9.4 Bile Duct Obstruction
7.1.9.5 Liver Cancer
7.1.9.6 Autoimmune Disorders
7.1.9.7 Others
7.1.10 Lipid Panel Testing
7.1.11 Renal Panel Testing
7.1.12 Cardiovascular Panel Tests
7.1.13 Others
7.2 Global Clinical Laboratory Tests Market (2017-2032) by Category
7.2.1 Market Overview
7.2.2 Clinical Chemistry
7.2.3 Genetics
7.2.4 Cytology
7.2.5 Hematology
7.2.6 Microbiology
7.2.7 Immunology
7.3 Global Clinical Laboratory Tests Market (2017-2032) by Patient Type
7.3.1 Market Overview
7.3.2 Adult
7.3.3 Geriatrics
7.4 Global Clinical Laboratory Tests Market (2017-2032) by Service Provider
7.4.1 Market Overview
7.4.2 Hospital-based Laboratories
7.4.3 Stand-alone Laboratories
7.4.4 Clinic-based Laboratories
7.5 Global Clinical Laboratory Tests Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Clinical Laboratory Tests Market (2017-2032)
8.1 North America Clinical Laboratory Tests Market (2017-2032) by Test Type
8.1.1 Market Overview
8.1.2 Complete Blood Count
8.1.3 Basic Metabolic Panel Testing
8.1.4 HGB/ HCT testing
8.1.5 Comprehensive Metabolic Panel Testing
8.1.6 BUN Creatinine Testing
8.1.7 HbA1c Testing
8.1.8 Electrolytes Testing
8.1.9 Liver Panel Testing
8.1.9.1 Hepatitis
8.1.9.2 Liver Cirrhosis
8.1.9.3 Bone Disease
8.1.9.4 Bile Duct Obstruction
8.1.9.5 Liver Cancer
8.1.9.6 Autoimmune Disorders
8.1.9.7 Others
8.1.10 Lipid Panel Testing
8.1.11 Renal Panel Testing
8.1.12 Cardiovascular Panel Tests
8.1.13 Others
8.2 North America Clinical Laboratory Tests Market (2017-2032) by Category
8.2.1 Market Overview
8.2.2 Clinical Chemistry
8.2.3 Genetics
8.2.4 Cytology
8.2.5 Hematology
8.2.6 Microbiology
8.2.7 Immunology
8.3 North America Clinical Laboratory Tests Market (2017-2032) by Patient Type
8.3.1 Market Overview
8.3.2 Adult
8.3.3 Geriatrics
8.4 North America Clinical Laboratory Tests Market (2017-2032) by Service Provider
8.4.1 Market Overview
8.4.2 Hospital-based Laboratories
8.4.3 Stand-alone Laboratories
8.4.4 Clinic-based Laboratories
8.5 North America Clinical Laboratory Tests Market (2017-2032) by Country
8.5.1 United States of America
8.5.2 Canada
9 Europe Clinical Laboratory Tests Market (2017-2032)
9.1 Europe Clinical Laboratory Tests Market (2017-2032) by Test Type
9.1.1 Market Overview
9.1.2 Complete Blood Count
9.1.3 Basic Metabolic Panel Testing
9.1.4 HGB/ HCT testing
9.1.5 Comprehensive Metabolic Panel Testing
9.1.6 BUN Creatinine Testing
9.1.7 HbA1c Testing
9.1.8 Electrolytes Testing
9.1.9 Liver Panel Testing
9.1.9.1 Hepatitis
9.1.9.2 Liver Cirrhosis
9.1.9.3 Bone Disease
9.1.9.4 Bile Duct Obstruction
9.1.9.5 Liver Cancer
9.1.9.6 Autoimmune Disorders
9.1.9.7 Others
9.1.10 Lipid Panel Testing
9.1.11 Renal Panel Testing
9.1.12 Cardiovascular Panel Tests
9.1.13 Others
9.2 Europe Clinical Laboratory Tests Market (2017-2032) by Category
9.2.1 Market Overview
9.2.2 Clinical Chemistry
9.2.3 Genetics
9.2.4 Cytology
9.2.5 Hematology
9.2.6 Microbiology
9.2.7 Immunology
9.3 Europe Clinical Laboratory Tests Market (2017-2032) by Patient Type
9.3.1 Market Overview
9.3.2 Adult
9.3.3 Geriatrics
9.4 Europe Clinical Laboratory Tests Market (2017-2032) by Service Provider
9.4.1 Market Overview
9.4.2 Hospital-based Laboratories
9.4.3 Stand-alone Laboratories
9.4.4 Clinic-based Laboratories
9.5 Europe Clinical Laboratory Tests Market (2017-2032) by Country
9.5.1 United Kingdom
9.5.2 Germany
9.5.3 France
9.5.4 Italy
9.5.5 Others
10 Asia Pacific Clinical Laboratory Tests Market (2017-2032)
10.1 Asia Pacific Clinical Laboratory Tests Market (2017-2032) by Test Type
10.1.1 Market Overview
10.1.2 Complete Blood Count
10.1.3 Basic Metabolic Panel Testing
10.1.4 HGB/ HCT testing
10.1.5 Comprehensive Metabolic Panel Testing
10.1.6 BUN Creatinine Testing
10.1.7 HbA1c Testing
10.1.8 Electrolytes Testing
10.1.9 Liver Panel Testing
10.1.9.1 Hepatitis
10.1.9.2 Liver Cirrhosis
10.1.9.3 Bone Disease
10.1.9.4 Bile Duct Obstruction
10.1.9.5 Liver Cancer
10.1.9.6 Autoimmune Disorders
10.1.9.7 Others
10.1.10 Lipid Panel Testing
10.1.11 Renal Panel Testing
10.1.12 Cardiovascular Panel Tests
10.1.13 Others
10.2 Asia Pacific Clinical Laboratory Tests Market (2017-2032) by Category
10.2.1 Market Overview
10.2.2 Clinical Chemistry
10.2.3 Genetics
10.2.4 Cytology
10.2.5 Hematology
10.2.6 Microbiology
10.2.7 Immunology
10.3 Asia Pacific Clinical Laboratory Tests Market (2017-2032) by Patient Type
10.3.1 Market Overview
10.3.2 Adult
10.3.3 Geriatrics
10.4 Asia Pacific Clinical Laboratory Tests Market (2017-2032) by Service Provider
10.4.1 Market Overview
10.4.2 Hospital-based Laboratories
10.4.3 Stand-alone Laboratories
10.4.4 Clinic-based Laboratories
10.5 Asia Pacific Clinical Laboratory Tests Market (2017-2032) by Country
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 ASEAN
10.5.5 Australia
10.5.6 Others
11 Latin America Clinical Laboratory Tests Market (2017-2032)
11.1 Latin America Clinical Laboratory Tests Market (2017-2032) by Test Type
11.1.1 Market Overview
11.1.2 Complete Blood Count
11.1.3 Basic Metabolic Panel Testing
11.1.4 HGB/ HCT testing
11.1.5 Comprehensive Metabolic Panel Testing
11.1.6 BUN Creatinine Testing
11.1.7 HbA1c Testing
11.1.8 Electrolytes Testing
11.1.9 Liver Panel Testing
11.1.9.1 Hepatitis
11.1.9.2 Liver Cirrhosis
11.1.9.3 Bone Disease
11.1.9.4 Bile Duct Obstruction
11.1.9.5 Liver Cancer
11.1.9.6 Autoimmune Disorders
11.1.9.7 Others
11.1.10 Lipid Panel Testing
11.1.11 Renal Panel Testing
11.1.12 Cardiovascular Panel Tests
11.1.13 Others
11.2 Latin America Clinical Laboratory Tests Market (2017-2032) by Category
11.2.1 Market Overview
11.2.2 Clinical Chemistry
11.2.3 Genetics
11.2.4 Cytology
11.2.5 Hematology
11.2.6 Microbiology
11.2.7 Immunology
11.3 Latin America Clinical Laboratory Tests Market (2017-2032) by Patient Type
11.3.1 Market Overview
11.3.2 Adult
11.3.3 Geriatrics
11.4 Latin America Clinical Laboratory Tests Market (2017-2032) by Service Provider
11.4.1 Market Overview
11.4.2 Hospital-based Laboratories
11.4.3 Stand-alone Laboratories
11.4.4 Clinic-based Laboratories
11.5 Latin America Clinical Laboratory Tests Market (2017-2032) by Country
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Mexico
11.5.4 Others
12 Middle East and Africa Clinical Laboratory Tests Market (2017-2032)
12.1 Middle East and Africa Clinical Laboratory Tests Market (2017-2032) by Test Type
12.1.1 Market Overview
12.1.2 Complete Blood Count
12.1.3 Basic Metabolic Panel Testing
12.1.4 HGB/ HCT testing
12.1.5 Comprehensive Metabolic Panel Testing
12.1.6 BUN Creatinine Testing
12.1.7 HbA1c Testing
12.1.8 Electrolytes Testing
12.1.9 Liver Panel Testing
12.1.9.1 Hepatitis
12.1.9.2 Liver Cirrhosis
12.1.9.3 Bone Disease
12.1.9.4 Bile Duct Obstruction
12.1.9.5 Liver Cancer
12.1.9.6 Autoimmune Disorders
12.1.9.7 Others
12.1.10 Lipid Panel Testing
12.1.11 Renal Panel Testing
12.1.12 Cardiovascular Panel Tests
12.1.13 Others
12.2 Middle East and Africa Clinical Laboratory Tests Market (2017-2032) by Category
12.2.1 Market Overview
12.2.2 Clinical Chemistry
12.2.3 Genetics
12.2.4 Cytology
12.2.5 Hematology
12.2.6 Microbiology
12.2.7 Immunology
12.3 Middle East and Africa Clinical Laboratory Tests Market (2017-2032) by Patient Type
12.3.1 Market Overview
12.3.2 Adult
12.3.3 Geriatrics
12.4 Middle East and Africa Clinical Laboratory Tests Market (2017-2032) by Service Provider
12.4.1 Market Overview
12.4.2 Hospital-based Laboratories
12.4.3 Stand-alone Laboratories
12.4.4 Clinic-based Laboratories
12.5 Middle East and Africa Clinical Laboratory Tests Market (2017-2032) by Country
12.5.1 Saudi Arabia
12.5.2 United Arab Emirates
12.5.3 Nigeria
12.5.4 South Africa
12.5.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Strategic Initiatives
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership and Collaborations
14.3 Analysis by Joint Ventures
14.4 Analysis by Leading Players
14.5 Analysis by Geography
15 Supplier Landscape
15.1 Market Share Analysis, By Region (Top 5 Companies)
15.1.1 Market Share Analysis: Global
15.1.2 Market Share Analysis: North America
15.1.3 Market Share Analysis: Europe
15.1.4 Market Share Analysis: Asia Pacific
15.1.5 Market Share Analysis: Others
15.2 ARUP Laboratories
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Opko Health, Inc.
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Bioscientia Institut für Medizinische Diagnostik GmbH
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 NeoGenomics Laboratories, Inc.
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Mayo Clinic Laboratories
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Laboratory Corporation of America Holdings
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Spectra Laboratories, Inc.
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Eurofins Scientific
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 SYNLAB International
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 Quest Diagnostics Incorporated.
15.11.1 Financial Analysis
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Global Clinical Laboratory Tests Market – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER